Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy. (Record no. 26934822)

MARC details
000 -LEADER
fixed length control field 01662 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517142203.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201801s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1879-0852
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ejca.2016.12.027
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pradere, P
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180116
245 00 - TITLE STATEMENT
Title Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of cancer (Oxford, England : 1990)
Date of publication, distribution, etc. 04 2017
300 ## - PHYSICAL DESCRIPTION
Extent 308-309 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspergillosis, Allergic Bronchopulmonary
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunocompromised Host
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunosuppressive Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Programmed Cell Death 1 Receptor
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sunitinib
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Michot, J M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Champiat, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Danlos, F X
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marabelle, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lambotte, O
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Albiges, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Le Pavec, J
773 0# - HOST ITEM ENTRY
Title European journal of cancer (Oxford, England : 1990)
Related parts vol. 75
-- p. 308-309
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ejca.2016.12.027">https://doi.org/10.1016/j.ejca.2016.12.027</a>
Public note Available from publisher's website

No items available.